Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrosomal protein 43 (CEP43), also known as FGFR1 oncogene partner (FGFR1OP or FOP), is a hydrophilic centrosomal protein that plays a critical role in anchoring microtubules to centrosomes and is required for ciliation[1][3][10][11]. A t(6;8)(q27;p11) chromosomal translocation fusing CEP43 (FGFR1OP) to fibroblast growth factor receptor 1 (FGFR1) is implicated in certain myeloproliferative disorders[1][5]. Additionally, alterations in CEP43 are associated with immune-mediated diseases such as Crohn’s disease, Graves’ disease, and vitiligo[1]. No drugs are currently known to target CEP43 directly, and it is not generally considered a classical therapeutic target (e.g., receptor, enzyme, transporter)[1][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centrosomal protein 43 (CEP43).